Hungarian Brain Research Program(2017-1.2.1-NKP-2017-00002)
(K129065)
Szakterületek:
Onkológia
Objective: Hungary has one of the highest incidences and mortality rates of lung cancer
(LC), therefore the objective of this study was to analyse and compare LC incidence
and mortality rates between the main Hungarian regions.Methods: This nationwide, retrospective
study used data from the National Health Insurance Fund and included patients aged
≥20 years who were diagnosed with lung cancer (ICD-10 C34) between Jan 1, 2011 and
Dec 31, 2016. Age-standardized incidence and mortality rates were calculated and compared
for the main regions.Results: The highest incidence rate in males was recorded in
Northern Hungary (146.8/100,000 person-years [PY]), while the lowest rate was found
in Western Transdanubia (94.7/100,000 PY in 2011). All rates showed a declining trend
between 2011 and 2016, with the largest decrease in the Northern Great Plain (−20.0%;
p = 0.008). LC incidence and mortality rates in women both showed a rising tendency
in all regions of Hungary, reaching the highest in Central Hungary (59.86/100,000
PY in 2016). Lung cancer incidence and mortality rates in males correlated with the
level of education and smoking prevalence (p = 0.006 and p = 0.01, respectively) in
the regions. A correlation with GDP per capita and Health Development Index (HDI)
index could also be observed in the Hungarian regions, although these associations
were not statistically significant. No correlations could be detected between these
parameters among females.Conclusion: This analysis revealed considerable differences
in the epidemiology of LC between the 7 main Hungarian regions. LC incidence and mortality
rates significantly correlated with smoking and certain socioeconomic factors in men,
but not in women. Further research is needed to explain the regional differences.